Cite
Belluti S, Semeghini V, Rigillo G, et al. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients. J Exp Clin Cancer Res. 2021;40(1):362doi: 10.1186/s13046-021-02166-4.
Belluti, S., Semeghini, V., Rigillo, G., Ronzio, M., Benati, D., Torricelli, F., Reggiani Bonetti, L., Carnevale, G., Grisendi, G., Ciarrocchi, A., Dominici, M., Recchia, A., Dolfini, D., & Imbriano, C. (2021). Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients. Journal of experimental & clinical cancer research : CR, 40(1), 362. https://doi.org/10.1186/s13046-021-02166-4
Belluti, Silvia, et al. "Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients." Journal of experimental & clinical cancer research : CR vol. 40,1 (2021): 362. doi: https://doi.org/10.1186/s13046-021-02166-4
Belluti S, Semeghini V, Rigillo G, Ronzio M, Benati D, Torricelli F, Reggiani Bonetti L, Carnevale G, Grisendi G, Ciarrocchi A, Dominici M, Recchia A, Dolfini D, Imbriano C. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients. J Exp Clin Cancer Res. 2021 Nov 15;40(1):362. doi: 10.1186/s13046-021-02166-4. PMID: 34782004; PMCID: PMC8594157.
Copy
Download .nbib